| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.83B | 19.95B | 19.82B | 19.64B | 19.06B | 19.87B |
| Gross Profit | 20.32B | 18.80B | 19.58B | 19.42B | 18.81B | 19.54B |
| EBITDA | 17.35B | 4.62B | 3.26B | 2.53B | 3.57B | 3.12B |
| Net Income | 2.47B | 2.50B | 1.72B | 1.28B | 2.04B | 1.57B |
Balance Sheet | ||||||
| Total Assets | 1.70T | 1.68T | 1.63T | 1.61T | 1.70T | 1.71T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 127.11B | 85.98B | 104.37B | 237.74B | 231.90B |
| Total Debt | 112.83B | 88.10B | 70.20B | 52.10B | 138.00B | 117.34B |
| Total Liabilities | 1.62T | 1.60T | 1.55T | 1.53T | 1.62T | 1.63T |
| Stockholders Equity | 78.15B | 74.98B | 77.65B | 73.11B | 76.98B | 79.23B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 13.54B | 11.56B | -139.63B | -4.52B | 142.68B |
| Operating Cash Flow | 0.00 | 14.19B | 1.60B | -139.40B | -4.19B | 143.44B |
| Investing Cash Flow | 0.00 | 846.00M | -19.40B | 6.62B | 10.63B | -1.67B |
| Financing Cash Flow | 0.00 | -649.00M | -592.00M | -589.00M | -592.00M | -736.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥27.36B | 10.85 | ― | 3.50% | 16.60% | -5.51% | |
72 Outperform | ¥15.84B | 10.05 | ― | 3.58% | 13.77% | 19.08% | |
69 Neutral | ¥19.99B | 10.12 | ― | 3.37% | 3.70% | 24.98% | |
69 Neutral | ¥15.26B | 10.41 | ― | 3.74% | 5.91% | 5.03% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | ¥33.89B | 13.52 | ― | 2.59% | 4.90% | ― | |
64 Neutral | ¥17.78B | 10.10 | ― | 3.30% | 11.93% | 36.32% |